TBCRC 008: Early Change in <sup>18</sup>F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast Cancer
Roisín M. Connolly(Johns Hopkins University), Vered Stearns(Johns Hopkins University), Xian Zhou(The University of Texas Health Science Center at Houston), John H. Fetting(Johns Hopkins University), Joyce Mhlanga(Johns Hopkins University), Penny Powers(Parkland Health & Hospital System), Richard L. Wahl(Mallinckrodt (United States)), Antonio C. Wolff(Johns Hopkins University), Edward Gabrielson(Johns Hopkins University), Judy C. Boughey(Mayo Clinic in Arizona), Nancy E. Davidson(WinnMed), Kostandinos Sideras(Mayo Clinic in Florida), Lisa K. Jacobs(Johns Hopkins University), Lisa A. Carey(University of North Carolina at Chapel Hill), Anna Maria Storniolo(Indiana University Health), Bridget A. Walsh(Johns Hopkins University), Joo Hyun O(Korean Nuclear Society), Jane Zorzi(Parkland Health & Hospital System), Zhe Zhang(Peking University), Stanley P. Watkins(Anne Arundel Medical Center), Stacie C. Jeter(Johns Hopkins University), Nagi F. Khouri(Johns Hopkins University), John T. Carpenter(University of Louisville Hospital), Robert S. Miller(American Society of Clinical Oncology), Jeffrey P. Leal(Johns Hopkins University), Matthew P. Goetz(Mayo Clinic)
Cited by 65
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k